PatientsVille.com Logo

PatientsVille

Magne Side Effects

Common Magne Side Effects


The most commonly reported Magne side effects (click to view or check a box to report):

Nephrogenic Systemic Fibrosis (920)
Urticaria (818)
Nausea (602)
Pruritus (564)
Dyspnoea (541)
Vomiting (530)
Erythema (514)
Anxiety (455)
Pain (453)
Joint Range Of Motion Decreased (438)
Oedema Peripheral (393)
Mobility Decreased (371)
Emotional Distress (365)
Arthralgia (343)
Fibrosis (341)
Deformity (266)
Injury (255)
Joint Stiffness (253)
Asthenia (248)
Joint Contracture (240)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Magne Side Effects Reported to FDA

The following Magne reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Magne on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Hypoaesthesia, Erythema, Oedema Mouth, Swelling Face
This is a report of a 36-year-old female patient (weight: NA) from US, suffering from the following symptoms/conditions: nuclear magnetic resonance imaging,haemangioma, who was treated with Magnevist (dosage: Unk Unk, Once, start time: Feb 24, 2014), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Hypoaesthesia
  • Erythema
  • Oedema Mouth
  • Swelling Face
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Magnevist treatment in female patients, resulting in hypoaesthesia side effect.

Throat Irritation, Paraesthesia Mucosal
This report suggests a potential Magnevist Throat Irritation, Paraesthesia Mucosal side effect(s) that can have serious consequences. A 37-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: nuclear magnetic resonance imaging and used Magnevist (dosage: Unk Unk, Once) starting Mar 05, 2012. Soon after starting Magnevist the patient began experiencing various side effects, including:
  • Throat Irritation
  • Paraesthesia Mucosal
Drugs used concurrently: NA. Although Magnevist demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as throat irritation, may still occur.

Nausea
This Nausea problem was reported by a health professional from US. A 56-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: nuclear magnetic resonance imaging. On Feb 28, 2014 this consumer started treatment with Magnevist (dosage: Unk). The following drugs were being taken at the same time: NA. When commencing Magnevist, the patient experienced the following unwanted symptoms/side effects:
  • Nausea
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as nausea, may become evident only after a product is in use by the general population.

Vomiting, Sneezing
This is a report of a 38-year-old female patient (weight: NA) from US. The patient developed the following symptoms/conditions: nuclear magnetic resonance imaging and was treated with Magnevist (dosage: Unk Unk, Once) starting Feb 24, 2014. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
  • Vomiting
  • Sneezing
This opens a possibility that Magnevist treatment could cause the above reactions, including vomiting, and some female subjects may be more susceptible.


Rash, Vomiting, Nausea
A 31-year-old female patient (weight: NA) from US with the following symptoms/conditions: nuclear magnetic resonance imaging started Magnevist treatment (dosage: Unk Unk, Once) on Feb 25, 2014. Soon after starting Magnevist treatment, the subject experienced various side effects, including:
  • Rash
  • Vomiting
  • Nausea
Concurrently used drugs: NA. This finding indicates that some female patients could be more vulnerable to Magnevist.

Hypertension
A 76-year-old male patient from US (weight: NA) experienced symptoms, such as: NA and was treated with Magnesium (magnesium)(dosage: NA). The treatment was initiated on NS. After that a consumer reported the following side effect(s):
  • Hypertension
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Magnesium (magnesium) efficacy:
  • Iclusig (ponatinib) Tablet, 15mg
  • Cisplatin (cisplatin)
  • Coreg (carvedilol)
  • Pradaxa (dabigatran Etexilate Mesilate)
  • Nifedical Er (nifedipine)
  • Lovaza (omega-3-acid Ethyl Ester) Capsule


Paraesthesia, Unresponsive To Stimuli
In this report, Magnevist was administered for the following condition: scan brain,convulsion.A 62-year-old male consumer from US (weight: NA) started Magnevist treatment (dosage: 20 Ml, Once) on Feb 17, 2014.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Paraesthesia
  • Unresponsive To Stimuli
A possible interaction with other drugs could have contributed to this reaction: NA.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Magnevist treatment could be related to the listed above side effect(s).

Blood Pressure Systolic Increased, Respiratory Rate Increased, Dyspnoea, Wheezing, Eye Pruritus, Cough, Pain
This is a report of the following Magnevist (gadopentetate Dimelumine) side effect(s):
  • Blood Pressure Systolic Increased
  • Respiratory Rate Increased
  • Dyspnoea
  • Wheezing
  • Eye Pruritus
  • Cough
  • Pain
A 23-year-old male patient from US (weight: NA) presented with the following condition: scan with contrast and received a treatment with Magnevist (gadopentetate Dimelumine) (dosage: 19 Ml One Time Dose, Iv Via Power Inection) starting: Dec 04, 2013.The following concurrently used drugs could have generated interactions: NA.The patient was hospitalized.This report suggests that a Magnevist (gadopentetate Dimelumine) treatment could be associated with the listed above side effect(s).

Stevens-johnson Syndrome, Oral Mucosa Erosion, Abnormal Sensation In Eye, Erythema, Skin Erosion, Epidermal Necrosis
This Magnevist report was submitted by a 38-year-old female consumer from JP (weight: NA). The patient was diagnosed with: nuclear magnetic resonance imaging abdominal,ovarian cancer,antipyresis and Magnevist was administered (dosage: 10 Ml (1ml/s For About 10 Seconds), Once) starting: Jan 15, 2014. The consumer developed a set of symptoms:
  • Stevens-johnson Syndrome
  • Oral Mucosa Erosion
  • Abnormal Sensation In Eye
  • Erythema
  • Skin Erosion
  • Epidermal Necrosis
Other drugs used simultaneously: NA.Those unexpected symptoms could be linked to a Magnevist treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Respiratory Distress, Dizziness, Headache, Urticaria
This is a report of a possible correlation between Magnevist use and the following symptoms/side effect(s):
  • Respiratory Distress
  • Dizziness
  • Headache
  • Urticaria
which could contribute to an assessment of Magnevist risk profile.A 59-year-old female consumer from VI (weight: NA) was suffering from nuclear magnetic resonance imaging abdominal and was treated with Magnevist (dosage: 17 Ml, Once) starting Jan 23, 2014.Other concurrent medications: NA.

Erythema, Anaphylactic Reaction, Distributive Shock, Slow Response To Stimuli
A 40-year-old female patient from JP (weight: NA) presented with the following symptoms: nuclear magnetic resonance imaging abdominal,ovarian cancer,anaemia and after a treatment with Magnevist (dosage: 14 Ml, Once) experienced the following side effect(s):
  • Erythema
  • Anaphylactic Reaction
  • Distributive Shock
  • Slow Response To Stimuli
The treatment was started on Oct 29, 2013. Magnevist was used in combination with the following drugs: NA.The patient was hospitalized.This report could alert potential Magnevist consumers.

Paraesthesia Mucosal
In this report, a 58-year-old female patient from US (weight: NA) was affected by a possible Magnevist side effect.The patient was diagnosed with nuclear magnetic resonance imaging. After a treatment with Magnevist (dosage: 15 Ml, Once, start date: Jan 20, 2014), the patient experienced the following side effect(s):
  • Paraesthesia Mucosal
The following simultaneously used drugs could have led to this reaction: NA.The findings here stress that side effects should be taken into consideration when evaluating a Magnevist treatment.

Urticaria, Pruritus, Contrast Media Reaction
This is a report of a 31-year-old female patient from US (weight: NA), who used Magnevist (dosage: 14 Ml, Once) for a treatment of nuclear magnetic resonance imaging brain. After starting a treatment on Jan 14, 2014, the patient experienced the following side effect(s):
  • Urticaria
  • Pruritus
  • Contrast Media Reaction
The following drugs could possibly have interacted with the Magnevist treatment NA.Taken together, these observations suggest that a Magnevist treatment could be related to side effect(s), such as Urticaria, Pruritus, Contrast Media Reaction.

Tension Headache, Sensation Of Pressure, Anxiety
This tension headache side effect was reported by a health professional from US. A 71-year-old female patient (weight:NA) experienced the following symptoms/conditions: nuclear magnetic resonance imaging brain,hypoaesthesia. The patient was prescribed Magnevist (dosage: 15 Ml, Unk), which was started on Jan 13, 2014. Concurrently used drugs: NA. When starting to take Magnevist the consumer reported the following symptoms:
  • Tension Headache
  • Sensation Of Pressure
  • Anxiety
These side effects may potentially be related to Magnevist.

Tension Headache, Intracranial Pressure Increased
This is a Magnevist side effect report of a 51-year-old female patient (weight:NA) from US, suffering from the following symptoms/conditions: nuclear magnetic resonance imaging,headache, who was treated with Magnevist (dosage:18 Ml, Once, start time: Jan 13, 2014), combined with: NA., and developed a serious reaction and a tension headache side effect. The patient presented with:
  • Tension Headache
  • Intracranial Pressure Increased
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Magnevist treatment in female patients suffering from nuclear magnetic resonance imaging,headache, resulting in tension headache.

Pruritus
This report suggests a potential Magnevist pruritus side effect(s) that can have serious consequences. A 52-year-old female patient from US (weight:NA) was diagnosed with the following health condition(s): nuclear magnetic resonance imaging and used Magnevist (dosage: Unk Unk, Once) starting NS. Soon after starting Magnevist the patient began experiencing various side effects, including:
  • Pruritus
Drugs used concurrently:NA. Although Magnevist demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as pruritus, may still occur.

Toxicity To Various Agents
This toxicity to various agents problem was reported by a pharmacist from US. A 79-year-old male patient (weight: NA) was diagnosed with the following medical condition(s): NA.On NS a consumer started treatment with Magnesium Hydroxide (dosage: NA). The following drugs/medications were being taken at the same time:
  • Gabapentin
  • Acetaminophen
  • Hydrocodone
  • Ethanol
When commencing Magnesium Hydroxide, the patient experienced the following unwanted symptoms /side effects:
  • Toxicity To Various Agents
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as toxicity to various agents, may become evident only after a product is in use by the general population.

Pruritus, Flushing
This is a Magnevist side effect report of a 61-year-old female patient (weight: NA) from US. The patient developed the following symptoms/conditions: nuclear magnetic resonance imaging brain and was treated with Magnevist (dosage: Unk Unk, Once) starting Dec 09, 2013. Concurrently used drugs: NA. Soon after that, the consumer experienced the following of symptoms:
  • Pruritus
  • Flushing
This opens a possibility that Magnevist could cause pruritus and that some female patients may be more susceptible.

Urticaria
A 47-year-old female patient (weight: NA) from US with the following symptoms: nuclear magnetic resonance imaging breast started Magnevist treatment (dosage: 20 Ml, Once) on Dec 31, 2013. Soon after starting Magnevist treatment, the consumer experienced several side effects, including:
  • Urticaria
. Concurrently used drugs: NA. This finding indicates that some patients can be more vulnerable to developing Magnevist side effects, such as urticaria.

Urticaria
This urticaria side effect was reported by a health professional from US. A 57-year-old female patient (weight:NA) experienced the following symptoms/conditions: nuclear magnetic resonance imaging,breast disorder.The patient was prescribed Magnevist (dosage: 20 Ml, Once), which was started on Dec 30, 2013. Concurrently used drugs: NA..When starting to take Magnevist the consumer reported symptoms, such as:
  • Urticaria
These side effects may potentially be related to Magnevist.

Nephrogenic Systemic Fibrosis
This is a report of a 59-year-old female patient (weight: NA) from DK, suffering from the following symptoms/conditions: NA, who was treated with Magnevist (dosage: NA, start time: Jun 26, 2006), combined with:
  • Omniscan
  • Prednisolone
and developed a serious reaction and side effect(s). The consumer presented with:
  • Nephrogenic Systemic Fibrosis
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Magnevist treatment in female patients, resulting in nephrogenic systemic fibrosis side effect.

Phlebitis, Pain, Thrombosis
This report suggests a potential Magnevistan Phlebitis, Pain, Thrombosis side effect(s) that can have serious consequences. A 29-year-old male patient (weight: NA) from BR was diagnosed with the following symptoms/conditions: nuclear magnetic resonance imaging brain and used Magnevistan (dosage: NA) starting NS. Soon after starting Magnevistan the patient began experiencing various side effects, including:
  • Phlebitis
  • Pain
  • Thrombosis
Drugs used concurrently: NA. Although Magnevistan demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as phlebitis, may still occur.

Urticaria
This Urticaria problem was reported by a consumer or non-health professional from US. A 49-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: arteriogram. On Dec 17, 2013 this consumer started treatment with Magnevist (dosage: 35 Ml, Once). The following drugs were being taken at the same time: NA. When commencing Magnevist, the patient experienced the following unwanted symptoms/side effects:
  • Urticaria
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as urticaria, may become evident only after a product is in use by the general population.

Nephrogenic Systemic Fibrosis, Arthralgia, Musculoskeletal Stiffness, Joint Contracture, Mobility Decreased, Gait Disturbance, Abasia, Skin Discolouration, Joint Stiffness
This is a report of a 43-year-old male patient (weight: NA) from US. The patient developed the following symptoms/conditions: nuclear magnetic resonance imaging abdominal,complications of transplanted kidney,abdominal pain,angiogram,intestinal ischaemia,nuclear magnetic resonance imaging brain,blood prolactin increased and was treated with Magnevist (dosage: 20 Ml, Once) starting Oct 05, 2005. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
  • Nephrogenic Systemic Fibrosis
  • Arthralgia
  • Musculoskeletal Stiffness
  • Joint Contracture
  • Mobility Decreased
  • Gait Disturbance
  • Abasia
  • Skin Discolouration
  • Joint Stiffness
This opens a possibility that Magnevist treatment could cause the above reactions, including nephrogenic systemic fibrosis, and some male subjects may be more susceptible.

Anaphylactic Shock, Laryngeal Oedema, Dyspnoea, Cyanosis, Cardio-respiratory Arrest
A 58-year-old female patient (weight: NA) from BR with the following symptoms/conditions: nuclear magnetic resonance imaging abdominal started Magnevistan treatment (dosage: 15 Ml, Once) on Dec 10, 2013. Soon after starting Magnevistan treatment, the subject experienced various side effects, including:
  • Anaphylactic Shock
  • Laryngeal Oedema
  • Dyspnoea
  • Cyanosis
  • Cardio-respiratory Arrest
Concurrently used drugs: NA.The patient was hospitalized. This finding indicates that some female patients could be more vulnerable to Magnevistan.

1 of 225 



Top 10 Magne Side Effects for Women

Women Side EffectsReports
Urticaria 581
Nephrogenic Systemic Fibrosis 436
Pruritus 393
Nausea 356
Dyspnoea 322
Erythema 317
Vomiting 301
Pain 253
Joint Range Of Motion Decreased 223
Oedema Peripheral 217

Top 10 Magne Side Effects for Men

Men Side EffectsReports
Nephrogenic Systemic Fibrosis 484
Anxiety 243
Nausea 241
Vomiting 225
Urticaria 220
Joint Range Of Motion Decreased 215
Dyspnoea 212
Pain 200
Erythema 195
Emotional Distress 190

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Magne Side Effects

    Did You Have a Magne Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Magne for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Magne Safety Alerts, Active Ingredients, Usage Information

    NDC0054-3567
    TypeHUMAN OTC DRUG
    Proprietary NameMilk of Magnesia
    NameMilk of Magnesia
    Dosage FormCONCENTRATE
    RouteORAL
    On market since20010312
    LabelerRoxane Laboratories, Inc.
    Active Ingredient(s)MAGNESIUM HYDROXIDE
    Strength(s)2400
    Unit(s)mg/10mL
    Pharma Class

    More About Magne

    Side Effects reported to FDA: 5625

    Magne safety alerts: 2014 2011 2008 2007 2006 2005 2000

    Reported deaths: 474

    Reported hospitalizations: 648

    Proton Pump Inhibitor drugs (PPIs): Drug Safety Communication - Low Magnesium Levels Can Be Associated With Long-Term Use

    Prescription PPIs include Nexium (esomeprazole magnesium), Dexilant (dexlansoprazole), Prilosec (omeprazole), Zegerid (omeprazole and sodium bicarbonate), Prevacid (lansoprazole), Protonix (pantoprazole sodium), AcipHex (rabeprazole sodium), and Vimovo (a prescription combination drug product that contains a PPI (esomeprazole magnesium and naproxen).

    Over-the-counter (OTC) PPIs include Prilosec OTC (omeprazole), Zegerid OTC (omeprazole and sodium bicarbonate), and Prevacid 24HR (lansoprazole).

     

    [Posted 03/02/2011]

    AUDIENCE: Consumer, Gastroenterology, Family Practice

    ISSUE: FDA notified healthcare professionals and the public that prescription proton pump inhibitor (PPI) drugs may cause low serum magnesium levels (hypomagnesemia) if taken for prolonged periods of time (in most cases, longer than one year). Low serum magnesium levels can result in serious adverse events including muscle spasm (tetany), irregular heartbeat (arrhythmias), and convulsions (seizures); however, patients do not always have these symptoms. Treatment of hypomagnesemia generally requires magnesium supplements. In approximately one-quarter of the cases reviewed, magnesium supplementation alone did not improve low serum magnesium levels and the PPI had to be discontinued.

    BACKGROUND: PPIs work by reducing the amount of acid in the stomach and are used to treat conditions such as gastroesophageal reflux disease (GERD), stomach and small intestine ulcers, and inflammation of the esophagus.

    RECOMMENDATION: Healthcare professionals should consider obtaining serum magnesium levels prior to initiation of prescription PPI treatment in patients expected to be on these drugs for long periods of time, as well as patients who take PPIs with medications such as digoxin, diuretics or drugs that may cause hypomagnesemia. For patients taking digoxin, a heart medicine, this is especially important because low magnesium can increase the likelihood of serious side effects. Healthcare professionals should consider obtaining magnesium levels periodically in these patients. For additional information, refer to the Data Summary section of the FDA Drug Safety Communication.

    Healthcare professionals and patients are encouraged to report adverse events, side effects, or product quality problems related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

    • Complete and submit the report Online: www.fda.gov/MedWatch/report.htm
    • Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

     

    [03/02/2011 - Drug Safety Communication - FDA]

    Latest Magne clinical trials